307 related articles for article (PubMed ID: 23702908)
21. Analysis of Predictors of Type 2 Diabetes Mellitus Remission After Roux-en-Y Gastric Bypass in 101 Chinese Patients.
Yan W; Bai R; Li Y; Xu J; Zhong Z; Xing Y; Yan M; Lin Y; Song M
Obes Surg; 2019 Jun; 29(6):1867-1873. PubMed ID: 30798440
[TBL] [Abstract][Full Text] [Related]
22. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB.
Frenken M; Cho EY
Obes Facts; 2011; 4 Suppl 1(Suppl 1):13-7. PubMed ID: 22027284
[TBL] [Abstract][Full Text] [Related]
23. Obese Patients with Type 2 Diabetes: Outcomes After Laparoscopic Sleeve Gastrectomy.
Viscido G; Gorodner V; Signorini FJ; Biasoni AC; Navarro L; Rubin G; Obeide L; Moser F
J Laparoendosc Adv Surg Tech A; 2019 May; 29(5):655-662. PubMed ID: 30452318
[No Abstract] [Full Text] [Related]
24. Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review.
Chen Y; Zeng G; Tan J; Tang J; Ma J; Rao B
Diabetes Metab Res Rev; 2015 Oct; 31(7):653-62. PubMed ID: 25387821
[TBL] [Abstract][Full Text] [Related]
25. Midterm effects of bariatric surgery in patients with insulin-treated type 2 diabetes.
Ghio B; Jiménez A; Corcelles R; Flores L; Lacy A; Vidal J
Surg Obes Relat Dis; 2017 Dec; 13(12):2004-2009. PubMed ID: 28259559
[TBL] [Abstract][Full Text] [Related]
26. The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes.
Camerini GB; Papadia FS; Carlini F; Catalano M; Adami GF; Scopinaro N
Surg Obes Relat Dis; 2016 Feb; 12(2):345-9. PubMed ID: 26381876
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients.
Dogan K; Betzel B; Homan J; Aarts EO; Ploeger N; de Boer H; Aufenacker TJ; van Laarhoven CJ; Janssen IM; Berends FJ
Obes Surg; 2014 Nov; 24(11):1835-42. PubMed ID: 25027982
[TBL] [Abstract][Full Text] [Related]
28. Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30-35. The role of sRAGE biomarker as predictor of satisfactory outcomes.
Horwitz D; Saunders JK; Ude-Welcome A; Marie Schmidt A; Dunn V; Leon Pachter H; Parikh M
Surg Obes Relat Dis; 2016 Aug; 12(7):1337-1341. PubMed ID: 27134202
[TBL] [Abstract][Full Text] [Related]
29. Fasting glycemia: a good predictor of weight loss after RYGB.
Faria G; Preto J; Almeida AB; Guimarães JT; Calhau C; Taveira-Gomes A
Surg Obes Relat Dis; 2014; 10(3):419-24. PubMed ID: 24462312
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Fasting C-Peptide Predicts Type 2 Diabetes Mellitus Remission in Low-BMI Chinese Patients After Roux-en-Y Gastric Bypass.
Zhao L; Li W; Su Z; Liu Y; Zhu L; Zhu S
J Gastrointest Surg; 2018 Oct; 22(10):1672-1678. PubMed ID: 29845572
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of the metabolic effects of LSG and LRYGB in Chinese diabetes patients with BMI<35 kg/m
Du X; Zhou HX; Zhang SQ; Tian HM; Zhou ZG; Cheng Z
Surg Obes Relat Dis; 2017 Feb; 13(2):189-197. PubMed ID: 27720418
[TBL] [Abstract][Full Text] [Related]
32. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients.
Bruno G; Gruden G; Barutta F; Cavallo Perin P; Morino M; Toppino M
Surg Obes Relat Dis; 2015; 11(5):1014-9. PubMed ID: 25979204
[TBL] [Abstract][Full Text] [Related]
33. Preoperative insulin therapy as a marker for type 2 diabetes remission in obese patients after bariatric surgery.
Hariri K; Guevara D; Jayaram A; Kini SU; Herron DM; Fernandez-Ranvier G
Surg Obes Relat Dis; 2018 Mar; 14(3):332-337. PubMed ID: 29339030
[TBL] [Abstract][Full Text] [Related]
34. Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion.
Adami GF; Camerini G; Papadia F; Catalano MF; Carlini F; Cordera R; Scopinaro N
Obes Surg; 2019 Jan; 29(1):239-245. PubMed ID: 30232725
[TBL] [Abstract][Full Text] [Related]
35. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM
Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
[TBL] [Abstract][Full Text] [Related]
36. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
Moriconi D; Manca ML; Anselmino M; Rebelos E; Bellini R; Taddei S; Ferrannini E; Nannipieri M
Diabetes Metab; 2022 Jan; 48(1):101282. PubMed ID: 34547450
[TBL] [Abstract][Full Text] [Related]
37. Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores.
Lee WJ; Chong K; Chen SC; Zachariah J; Ser KH; Lee YC; Chen JC
Obes Surg; 2016 Oct; 26(10):2418-24. PubMed ID: 26932813
[TBL] [Abstract][Full Text] [Related]
38. Ethnicity Does Not Influence Glycemic Outcomes or Diabetes Remission After Sleeve Gastrectomy or Gastric Bypass in a Multiethnic Asian Cohort.
Lee PC; Tham KW; Ganguly S; Tan HC; Eng AKH; Dixon JB
Obes Surg; 2018 Jun; 28(6):1511-1518. PubMed ID: 29280058
[TBL] [Abstract][Full Text] [Related]
39. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.
Hall TC; Pellen MG; Sedman PC; Jain PK
Obes Surg; 2010 Sep; 20(9):1245-50. PubMed ID: 20524158
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass.
Almalki OM; Lee WJ; Chong K; Ser KH; Lee YC; Chen SC
Surg Obes Relat Dis; 2018 Apr; 14(4):509-515. PubMed ID: 29555031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
